News
Niger’s military-led government completed the nationalization of SOMAIR, a major uranium mining venture previously operated ...
Niger’s government says it will nationalize the Somaïr uranium venture operated by French company Orano over allegations that it took a disproportionate share of the uranium produced at the ...
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
Detailed price information for Molecular Partners Ag ADR (MOLN-Q) from The Globe and Mail including charting and trades.
LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the ...
New 40-person office in Oak Ridge leads the continuing development of Orano's planned multibillion-dollar uranium enrichment ...
With a new wave of renegotiations of mining licenses and stricter regulations, how are African countries, particularly in ...
Detailed price information for US Medical Devices Ishares ETF (IHI-A) from The Globe and Mail including charting and trades.
Molecular Partners and Orano Med expand collaboration to develop ten 212Pb-Radio-DARPin therapy candidates, initiating clinical trials in 2025. Molecular Partners AG and Orano Med have expanded ...
53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a ...
53 LR – Molecular Partners (MOLN) AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results